Peste des Petits Ruminants (PPR)

Peste des Petits Ruminants, commonly abbreviated as PPR and also known as goat plague, is a highly contagious and often fatal viral disease that primarily affects goats and sheep. This devastating illness is caused by a morbillivirus in the family Paramyxoviridae, closely related to the viruses that cause rinderpest in cattle and measles in humans. PPR is characterized by severe fever, respiratory distress, erosive stomatitis, diarrhea, and high mortality rates, making it one of the most economically significant diseases affecting small ruminant populations worldwide. The disease was first identified in West Africa in the 1940s and has since spread across much of Africa, the Middle East, and Asia, threatening the livelihoods of millions of farmers who depend on goats and sheep for their income and food security.

PPR affects both domestic and wild small ruminants, with goats generally experiencing more severe clinical signs and higher mortality rates compared to sheep. The disease is endemic in many regions across Africa south of the Sahara, the Arabian Peninsula, the Middle East, and large parts of Asia including the Indian subcontinent. Wild ungulates such as gazelles, ibex, and wild sheep are also susceptible and can serve as reservoir hosts. The Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health have identified PPR as a priority disease for global control and eradication, with the goal of eliminating the disease worldwide by 2030. Currently, PPR affects over 80 countries and threatens approximately 80 percent of the global small ruminant population.

The economic and welfare impact of PPR is staggering, with estimated annual losses exceeding two billion dollars globally due to animal mortality, reduced productivity, and trade restrictions. In affected regions, mortality rates can range from 50 to 90 percent in naive populations that have never encountered the virus. Beyond the direct financial losses, PPR has profound social implications as goats and sheep are critical to the livelihoods of smallholder farmers and pastoralist communities, providing meat, milk, fiber, and serving as valuable assets that can be sold during times of need. The loss of small ruminant herds to PPR can push vulnerable households deeper into poverty and food insecurity.

While there is no specific antiviral treatment for PPR, the disease is preventable through vaccination, and effective vaccines are available that provide lifelong immunity. Early detection and rapid response are critical for controlling outbreaks and preventing the spread of the virus to new areas. As a reportable disease in most countries, any suspected case of PPR must be immediately reported to veterinary authorities to enable swift implementation of control measures. Understanding the clinical signs, transmission dynamics, and prevention strategies for PPR is essential for goat and sheep producers, veterinarians, and animal health officials working to protect small ruminant populations and the communities that depend on them.

Peste des Petits Ruminants is caused by the Peste des Petits Ruminants virus (PPRV), a member of the genus Morbillivirus within the family Paramyxoviridae. This single-stranded RNA virus is closely related to rinderpest virus, canine distemper virus, and human measles virus, sharing similar structural characteristics and modes of transmission. Four distinct lineages of PPRV have been identified based on genetic analysis, with lineages I and II predominantly found in West Africa, lineage III in East Africa and the Middle East, and lineage IV distributed across Asia and the Middle East. All four lineages belong to a single serotype, meaning that vaccination against any lineage provides cross-protection against all others.

The primary mode of transmission is through direct contact between infected and susceptible animals. The virus is shed in large quantities in nasal and ocular secretions, saliva, urine, and feces of infected animals, particularly during the acute phase of illness. Close contact at water points, feeding areas, and during trading or transport facilitates rapid spread within and between herds. The virus can also be transmitted through aerosol droplets over short distances, especially in confined housing or during conditions that favor respiratory transmission. Contaminated bedding, equipment, and clothing can serve as fomites, though the virus has limited survival outside the host and is readily inactivated by heat, sunlight, and common disinfectants.

Several factors influence the susceptibility of animals to PPR infection and the severity of resulting disease. Young animals between three months and one year of age are particularly vulnerable, as maternal antibodies wane but active immunity has not yet developed. Animals that are malnourished, stressed, or suffering from concurrent infections are more likely to develop severe disease. Introduction of the virus into naive populations that have never been exposed results in explosive outbreaks with very high morbidity and mortality. In endemic areas where the virus circulates regularly, adult animals may have some degree of immunity from prior exposure, and outbreaks tend to be less severe.

Environmental and management factors play significant roles in PPR transmission dynamics. Seasonal movements of pastoralist herds, livestock markets, and festivals where animals are gathered create opportunities for the virus to spread across geographic areas. The dry season often sees increased transmission as animals congregate around limited water sources and pastures. Poor biosecurity practices, including mixing of animals from different sources without quarantine, failure to isolate sick animals, and inadequate disinfection protocols, facilitate introduction and spread of the virus within herds and farms.

The pathophysiology of PPR involves initial viral replication in the respiratory tract and regional lymph nodes following inhalation or ingestion of the virus. A viremic phase ensues during which the virus disseminates throughout the body, targeting epithelial tissues and lymphoid organs. Severe damage to the respiratory and gastrointestinal mucosa results in the characteristic erosive lesions and secondary bacterial infections. The profound immunosuppression caused by destruction of lymphoid tissue predisposes affected animals to opportunistic infections and contributes to the high mortality rates observed. Death typically results from dehydration due to severe diarrhea, respiratory failure from pneumonia, or overwhelming secondary bacterial infections.

The clinical presentation of Peste des Petits Ruminants varies depending on the virulence of the viral strain, the species affected, the age and immune status of the animal, and environmental factors. However, the classic syndrome follows a predictable progression from initial fever through respiratory and gastrointestinal manifestations to either death or gradual recovery. Goats typically display more pronounced clinical signs and suffer higher mortality compared to sheep, which may show milder or subclinical infections. The incubation period ranges from three to ten days following exposure, after which clinical signs appear abruptly.

The earliest warning signs of PPR infection include sudden onset of high fever, often reaching 40 to 41.5 degrees Celsius, accompanied by profound depression and loss of appetite. Affected animals become dull and listless, separating themselves from the rest of the herd. Fever persists for three to eight days and coincides with the period of viral shedding, making this early stage highly important for disease transmission. Producers who monitor their animals daily may notice reduced feed intake, decreased water consumption, and general malaise before more specific symptoms develop.

Respiratory symptoms become evident early in the disease course and progressively worsen. Initially, animals display serous nasal and ocular discharge that becomes increasingly mucopurulent as the disease advances. Crusting around the nostrils and eyes is common, and affected animals may have difficulty breathing through their noses. Coughing develops as the lower respiratory tract becomes involved, and harsh lung sounds may be detected on auscultation. In severe cases, dyspnea with open-mouth breathing and extension of the head and neck indicates respiratory distress. Secondary bacterial pneumonia frequently complicates the viral infection and significantly worsens the prognosis.

Characteristic erosive lesions in the mouth are a hallmark feature of PPR. Small areas of necrosis appear on the gums, dental pad, tongue, palate, inner cheeks, and pharynx. These lesions begin as pinpoint areas of necrosis that enlarge and coalesce to form irregular, shallow ulcers covered by yellowish-gray necrotic debris. The lips and muzzle often become swollen and may develop scabs. Excessive salivation is common due to oral pain, and affected animals are reluctant to eat. Similar lesions may occur in the vulva of females and the prepuce of males. The oral lesions, combined with the ocular and nasal discharge, create a characteristic syndrome that is highly suggestive of PPR.

Gastrointestinal involvement manifests as profuse, watery diarrhea that typically begins three to four days after the onset of fever. The feces may contain blood and mucus and have an extremely offensive odor. Dehydration develops rapidly due to fluid losses, and affected animals become progressively weak and emaciated. Tenesmus and soiling of the hindquarters are common findings. The combination of oral lesions preventing eating and severe diarrhea causing fluid and electrolyte losses leads to rapid deterioration in body condition and is a major contributor to mortality.

Severe and emergency symptoms that require immediate veterinary attention include complete refusal to eat or drink, profound weakness or recumbency, severe respiratory distress with cyanosis of mucous membranes, bloody diarrhea, neurological signs such as circling or head pressing, and collapse. Pregnant animals may abort. In peracute cases, death may occur within two to three days of symptom onset with minimal preceding clinical signs. The case fatality rate in naive populations typically ranges from 50 to 90 percent, though it may be lower in endemic areas where partial immunity exists. Animals that survive the acute phase begin to recover after approximately ten days but may remain weak and debilitated for weeks to months.

Diagnosis of Peste des Petits Ruminants requires a combination of clinical assessment, epidemiological information, and laboratory confirmation. Given the serious implications of a PPR diagnosis for trade and the requirement to report the disease to authorities, laboratory confirmation is essential. Clinical diagnosis alone can be challenging because several other diseases produce similar respiratory and gastrointestinal syndromes in small ruminants. A veterinarian should be contacted immediately whenever PPR is suspected based on clinical findings and the pattern of illness in the herd.

Clinical examination findings suggestive of PPR include the combination of high fever, mucopurulent nasal and ocular discharge, erosive stomatitis, and profuse diarrhea affecting multiple animals in a herd. The characteristic progression of symptoms and the high morbidity and mortality rates observed in outbreaks help differentiate PPR from other conditions. Epidemiological factors such as recent introduction of new animals, contact with other herds at markets or watering points, or location in an endemic region strengthen the clinical suspicion. Necropsy findings in animals that have died include erosive lesions throughout the alimentary tract, congested and consolidated lungs, and enlarged lymph nodes with characteristic giant cells on histopathology.

Laboratory diagnostic testing is required for definitive diagnosis and typically involves detection of viral antigen, nucleic acid, or antibodies in samples from affected animals. The virus can be identified in ocular and nasal swabs, blood samples during the febrile stage, and tissues collected at necropsy using techniques such as antigen-capture enzyme-linked immunosorbent assay and immunochromatographic lateral flow tests for rapid field diagnosis. Reverse transcription polymerase chain reaction provides highly sensitive and specific detection of viral RNA and allows for lineage identification. Virus isolation in cell culture remains the gold standard but requires specialized laboratory facilities and takes longer than molecular methods.

Differential diagnosis for PPR includes several other diseases that cause similar clinical syndromes in goats and sheep. Contagious caprine pleuropneumonia, pasteurellosis, bluetongue, foot-and-mouth disease, orf, goat pox, and heartwater must be considered depending on the geographic region and specific clinical presentation. Rinderpest, now officially eradicated, was historically an important differential diagnosis. For individual animals presenting with oral lesions, foot-and-mouth disease and orf are particularly important differentials. The presence of characteristic erosive stomatitis combined with respiratory and gastrointestinal signs in multiple animals helps distinguish PPR from conditions that typically affect only one body system. Laboratory testing is essential to definitively differentiate PPR from other look-alike diseases and to guide appropriate response measures.

There is no specific antiviral treatment available for Peste des Petits Ruminants, and management of affected animals relies on supportive care to help them survive the acute phase of illness while their immune system mounts a response against the virus. Treatment decisions in PPR outbreaks must balance individual animal welfare with herd-level disease control considerations and economic realities. Given the highly contagious nature of the disease and its reportable status, immediate isolation of affected animals and notification of veterinary authorities are priorities that supersede individual treatment.

Emergency intervention focuses on providing immediate supportive care to severely affected animals while implementing biosecurity measures to prevent further spread. Affected animals should be immediately isolated from the rest of the herd in a separate facility or area with dedicated equipment and personnel. Veterinary assistance should be sought urgently, and samples collected for laboratory confirmation. Pending diagnosis, the premises should be considered under quarantine with restricted movement of animals, people, and equipment. Animals with mild to moderate symptoms may recover with supportive care, but those with severe respiratory distress, profound dehydration, or recumbency have a guarded prognosis.

Medical management of PPR-affected animals centers on preventing secondary bacterial infections and correcting fluid and electrolyte imbalances. Broad-spectrum antibiotics such as oxytetracycline, penicillin combined with streptomycin, or sulfonamides are commonly administered to control secondary bacterial pneumonia and prevent septicemia. Withdrawal times for any medications used must be strictly observed for animals that recover, as goats and sheep are food-producing animals. Anti-inflammatory drugs may help reduce fever and improve comfort, though their use should be discussed with the attending veterinarian. Antiseptic mouth washes can provide some relief from oral lesions.

Supportive care is critical for survival and includes aggressive fluid therapy to combat dehydration from diarrhea and reduced intake. Oral electrolyte solutions can be administered to animals that are still able to swallow, while intravenous fluid therapy may be necessary for severely dehydrated individuals. Providing palatable, easily digestible feed and ensuring access to clean, fresh water encourage nutritional intake. Soft feeds that do not irritate oral lesions are preferred. Nursing care including keeping animals dry, clean, and warm and providing soft bedding improves comfort and may enhance recovery rates. Vitamin supplementation, particularly vitamin A, may support immune function.

At the herd level, treatment protocols must be integrated with disease control measures. In endemic areas where vaccination programs exist, ring vaccination around affected herds may help limit spread. In countries free of PPR, outbreak response typically involves stamping out policies with culling of infected and in-contact animals, though the feasibility of this approach depends on resources and the extent of spread. Movement restrictions, enhanced surveillance, and thorough cleaning and disinfection are components of any control program. Communication and coordination with veterinary authorities guide appropriate response measures.

Treatment decisions for individual animals must consider several factors including the severity of clinical signs, the likelihood of recovery, economic value of the animal, welfare implications of prolonged treatment, and disease control priorities. Animals with mild disease have reasonable prospects for recovery with supportive care. Those with severe respiratory compromise, protracted diarrhea, or marked debilitation may not recover despite treatment, and humane euthanasia should be considered to prevent prolonged suffering. The decision to treat versus cull should be made in consultation with the veterinarian and with consideration of regulatory requirements for disease control.

Recovery from Peste des Petits Ruminants in surviving animals follows a protracted course, with the acute clinical phase lasting approximately two to three weeks followed by a prolonged convalescent period. Animals that survive the initial viremic stage and do not succumb to secondary complications gradually regain their appetite and strength over a period of several weeks. Full recovery of body condition and productive capacity may take one to three months depending on the severity of illness and the quality of supportive care provided during convalescence. Recovered animals develop solid, lifelong immunity against all strains of the virus and are not carriers of the infection.

Post-treatment care and monitoring of recovering animals requires continued attention to nutritional support and observation for secondary complications. High-quality, easily digestible feed should be provided to promote weight gain and tissue repair. Fresh water must be available at all times. Animals should be monitored for signs of secondary bacterial infections, particularly pneumonia, which may develop or worsen even as other symptoms improve. Oral lesions typically heal within one to two weeks, and appetite gradually returns as mouth pain resolves. Diarrhea may persist for several days after fever subsides but should progressively improve. Animals that develop chronic respiratory disease or fail to regain body condition may have suffered permanent damage.

Prognosis for individual animals depends on several factors including the severity of initial clinical signs, the promptness of supportive care, the development of secondary complications, and the overall health status of the animal prior to infection. Mortality rates during outbreaks typically range from 50 to 90 percent in fully susceptible populations but may be lower in endemic areas or when aggressive supportive care is provided. Young animals, pregnant females, and those with concurrent health issues have poorer prognoses. Animals that survive and recover completely can be expected to return to normal productive lives.

Return to production for recovered animals requires assessment of their overall condition and consideration of any residual effects from the illness. Milk production in dairy goats may take several weeks to return to previous levels, and some animals may not fully regain their pre-illness productivity. Body condition should be restored before resuming breeding activities. Animals should be fully recovered and free of any ongoing symptoms before being mixed back with the general herd population. Since recovered animals are not persistent carriers and pose no ongoing transmission risk, they can safely rejoin the herd once clinically normal. Documentation of recovery status is important for regulatory purposes and for making management decisions about retained versus culled animals.

Vaccination is the cornerstone of PPR prevention and is highly effective in protecting goats and sheep from infection. Attenuated live vaccines based on the Nigeria 75/1 strain or the Sungri 96 strain are widely used and provide strong, long-lasting immunity with a single dose. Vaccination is recommended for all small ruminants in endemic areas starting at four months of age, when maternal antibodies have waned sufficiently to allow an active immune response. Annual revaccination was historically recommended, though evidence indicates that immunity from a single dose likely persists for life. Mass vaccination campaigns targeting at least 80 percent of the small ruminant population are necessary to achieve herd immunity and interrupt viral transmission.

Biosecurity measures are essential for preventing introduction of PPR into disease-free herds and for controlling spread during outbreaks. New animals should be sourced only from reputable suppliers with known health status and should be quarantined for at least three weeks before introduction to the main herd. During quarantine, animals should be observed for any signs of illness and ideally tested for PPR antibodies. Avoiding contact with animals of unknown health status at markets, shows, and communal grazing areas reduces exposure risk. Transport vehicles, equipment, and clothing that have been in contact with other small ruminants should be thoroughly cleaned and disinfected before contact with the home herd.

Nutritional management contributes to disease resistance by maintaining animals in good body condition and supporting robust immune function. Adequate provision of energy, protein, minerals, and vitamins helps animals mount effective immune responses if exposed to the virus. Avoiding sudden dietary changes and preventing nutritional deficiencies are particularly important during high-risk periods such as late pregnancy and early lactation. Stress reduction through appropriate management practices supports overall health and resilience.

Management practices that reduce disease transmission risk include avoiding overcrowding, providing adequate ventilation in housing, and maintaining clean and dry conditions. Sick animals should be promptly isolated to prevent spread to herdmates. Regular monitoring of animal health allows early detection of problems before they spread. Routine veterinary involvement in herd health planning helps ensure vaccination programs are current and biosecurity protocols are appropriate for the level of risk. Keeping good records of animal movements, health events, and vaccinations facilitates disease investigation if problems occur.

Quarantine and testing protocols are particularly important when introducing new animals or after potential exposure to infected herds. The standard quarantine period of three weeks allows time for clinical signs to develop if animals were incubating the disease at the time of purchase. Testing for PPR antibodies can help confirm prior vaccination or natural exposure but does not distinguish between the two. In regions where PPR is being controlled through vaccination campaigns, serosurveys and active surveillance help monitor progress toward elimination. Any suspicion of PPR based on clinical signs must be reported immediately to veterinary authorities to enable rapid response and prevent further spread.

Daily management and monitoring of goat herds in areas where PPR is endemic or poses a threat requires vigilance and attention to animal health. Producers should observe their animals at least twice daily, looking for signs of illness such as depression, reduced appetite, nasal discharge, coughing, or diarrhea. Early detection of disease allows prompt isolation of affected animals and reduces transmission to herdmates. Keeping animals in good body condition through appropriate nutrition supports their natural defenses against infection. During high-risk periods such as market seasons or when neighboring herds are experiencing illness, increased vigilance is warranted.

Housing and environmental management contribute to disease prevention by reducing stress and limiting opportunities for viral transmission. Shelters should provide protection from extreme weather while allowing adequate ventilation to reduce accumulation of respiratory pathogens. Overcrowding must be avoided as it increases stress and facilitates spread of infectious diseases. Clean, dry bedding should be maintained and replaced regularly. Feeding and watering equipment should be cleaned frequently to prevent buildup of contaminated material. Separation of age groups helps protect young, susceptible animals from exposure to pathogens that adult animals may carry.

Herd health programs should include PPR vaccination as a core component in endemic areas. Working with a veterinarian to develop a comprehensive health plan ensures that vaccination schedules are appropriate and that other health issues are addressed. Regular veterinary visits allow monitoring of herd health status and provide opportunities to update vaccination and biosecurity protocols based on current disease risks. Producers should maintain relationships with veterinary services so that professional assistance is readily available when health problems arise. Participation in disease surveillance and control programs benefits individual herds and the broader livestock community.

Record keeping and monitoring systems support effective disease management by documenting animal identities, vaccination histories, health events, and production data. Individual animal identification allows tracking of each animal's health status and helps trace contacts if disease occurs. Vaccination records should include the date of vaccination, the product used, and the identity of animals vaccinated. Mortality and morbidity events should be recorded along with any clinical findings and diagnostic results. Good records facilitate communication with veterinarians and regulatory authorities and support decision-making about culling, breeding, and purchasing animals.

Economic considerations for producers in PPR-endemic regions include the costs of vaccination, the potential losses from outbreaks, and the implications for market access. While vaccination programs require investment, this cost is far outweighed by the potential losses from PPR outbreaks, which can decimate herds and eliminate years of genetic progress. Access to premium markets may depend on demonstrated disease-free status or participation in recognized health programs. Insurance products may be available in some regions to help offset losses from disease outbreaks. Producers should factor disease risk and prevention costs into their overall business planning and maintain financial reserves to cope with health emergencies.

All breeds of goats are susceptible to Peste des Petits Ruminants, though some studies suggest variation in susceptibility and disease severity among breeds. Indigenous breeds in endemic areas may have developed some degree of natural resistance through generations of exposure to the virus, whereas exotic breeds introduced from PPR-free regions are typically fully susceptible and may experience more severe disease. West African Dwarf goats, Sahelian goats, and other local breeds in endemic regions often show lower mortality rates compared to European dairy breeds raised under similar conditions. However, even indigenous breeds suffer significant losses during outbreaks, and no breed can be considered resistant to PPR.

Production type influences disease risk primarily through management and exposure patterns rather than inherent breed characteristics. Extensively managed pastoral herds that travel long distances and commingle with other herds at water points and markets face high exposure risk. Intensive dairy operations may have better biosecurity and controlled animal movements but can experience devastating outbreaks if the virus is introduced. Meat goat operations with frequent buying and selling of animals are at particular risk due to the regular introduction of animals from external sources. Young stock between three months and one year of age are at highest risk regardless of breed or production system because maternal antibody protection has waned but active immunity has not yet developed.

Genetic selection for PPR resistance is not currently practical as no reliable genetic markers for resistance have been identified, and the focus remains on prevention through vaccination. Selection of breeding stock should prioritize overall health and productivity rather than attempting to select for disease resistance. Producers introducing new genetics into their herds should ensure animals come from reputable sources with documented vaccination and health status. Testing of imported animals may be required depending on the origin and destination regions. Maintaining diverse genetic stock can help ensure herd resilience in the face of various health and environmental challenges.

Several conditions commonly co-occur with or follow Peste des Petits Ruminants infection, primarily due to the profound immunosuppression caused by the virus. Secondary bacterial pneumonia is extremely common, with organisms such as Mannheimia haemolytica and Pasteurella multocida taking advantage of the damaged respiratory epithelium and compromised immune defenses. These bacterial infections may persist even after the viral phase has resolved and require antibiotic therapy. Parasitic infections, particularly gastrointestinal nematodes and coccidia, may flare up in immunosuppressed animals and contribute to diarrhea and wasting. Nutritional deficiencies may develop as a consequence of prolonged illness, reduced intake, and increased metabolic demands.

Conditions with similar symptoms that must be distinguished from PPR include contagious caprine pleuropneumonia, which causes severe respiratory disease in goats but lacks the oral and gastrointestinal involvement seen in PPR. Foot-and-mouth disease produces oral and foot lesions but is not typically associated with the respiratory syndrome of PPR. Bluetongue causes fever and oral lesions but affects sheep more severely than goats and is transmitted by biting midges rather than direct contact. Goat pox and sheep pox produce characteristic skin lesions that help differentiate them from PPR. Orf causes proliferative lesions around the mouth rather than erosive lesions. Heartwater causes fever and neurological signs in regions where the tick vector is present.

Complications and sequelae of PPR infection can affect animals that survive the acute phase. Chronic respiratory disease may develop as a consequence of lung damage during the acute illness, particularly if secondary bacterial pneumonia was severe. Reduced productivity including lower milk yield and impaired weight gain may persist for weeks to months during recovery. Abortion in pregnant animals may occur during the acute illness or in the weeks following apparent recovery. Immunosuppression may predispose recovered animals to other infectious diseases during the convalescent period. Despite these potential sequelae, animals that fully recover develop solid immunity and should return to normal productive function with appropriate supportive care during convalescence.